SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5.81 |
Enterprise Value ($M) | 34.15 |
Book Value ($M) | -56.48 |
Book Value / Share | -0.88 |
Price / Book | -0.10 |
NCAV ($M) | -73.31 |
NCAV / Share | -1.15 |
Price / NCAV | -0.08 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.22 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.08 |
Current Ratio | 0.11 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.77 |
Assets | 23.60 |
Liabilities | 80.08 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 16.65 |
Operating Income | -1.89 |
Net Income | -6.45 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -2.29 |
Cash from Investing | 2.50 |
Cash from Financing | -1.35 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Lim Seah H. | 6.50 | -9.58 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Similar Companies | |
---|---|
ELOX – Eloxx Pharmaceuticals, Inc. | ELTP – Elite Pharmaceuticals, Inc. |
ELVAF – Evolva Holding SA | ENZB – Enzo Biochem, Inc. |
ENZN – Enzon Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io